Navigation Links
Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
Date:1/21/2009

ilities for microbial production. Richter-Helm offers highly specialised contract development and manufacturing services for the pharmaceutical and biotechnological industries. Additionally, Richter-Helm is seeking for interesting biopharmaceutical development projects for its own pipeline and for co-development with partners.http://www.richter-helm.eu

    Contact:
    Dr. Kai Pohlmeyer, Head of Business Development
    Phone: +49-40-2375-1430
    Mail: k.pohlmeyer@richter-helm-biotec.eu

About Athera Biotechnologies

Athera provides new opportunities for treatment and prevention of cardiovascular disease. The company has an innovative pipeline of drug candidates and risk markers enabling a possibility to provide a true combination of diagnosis and treatment. On Oct 2, 2008 Athera announced a collaboration with Dyax Corp. (NASDAQ: DYAX) to discover and develop antibodies for treatment of cardiovascular inflammation. The therapy is based on phosphorylcholine (PC) and low levels of antibodies to PC in human serum have been linked with an increased risk of developing cardiovascular disease. Athera Biotechnologies is based in Karolinska Institutet Science Park in Stockholm and main investors include Karolinska Development and Baltic Sea Foundation. Athera is also a major partner in the highly ranked EU-project CVDIMMUNE lead by Karolinska Institutet. The project involves 10 academic and industrial partners, also including TNO, Phadia GmbH and Johannes Gutenberg-University Mainz. http://www.athera.se

    Contact:
    Carina Schmidt, CEO
    Phone: +46705525115
    Mail: c.schmidt@athera.se

'/>"/>
SOURCE Richter-Helm BioLogics GmbH & Co. KG and Athera Biotechnologies AB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
2. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
5. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
6. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
7. Amyris Biotechnologies Announces $70 Million Series B Round
8. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
9. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
10. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
11. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced that Jeffrey ... two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ) ... Annual Marcum LLP Microcap Conference on Thursday, May 30, ... City.  The presentation is scheduled to begin at 4:30 ...
(Date:5/23/2013)... 23, 2013 Pusan National University Yangsan ... biotherapeutics and contract research company focused on research ... announced today a publication reporting the induction of ... oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex ... in the May 15 th , 2013 issue ...
(Date:5/23/2013)... May 23, 2013 African ... tracing for people of African descent, today announced ... offering. For people of all races, myDNAmix determines ... five distinct populations: Indigenous Americas (Native American), East ... Subcontinent. , Originally launched in late ...
(Date:5/23/2013)... 2013 Bed bugs compromised Penn ... already confirmed it. Meanwhile, My Cleaning Products offered complimentary samples ... fight the pests without using harmful chemical elements. , ... 2013, the affected building was actually a dormitory , ... said made on May 13 and bed bug presence was ...
Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... Harriet L. Robinson, Ph.D., Chief Scientific Officer at ... in the development of HIV/AIDS vaccines, announced the results ... step closer to a vaccine that protects against multiple ... by Dr. Robinson during a presentation in Seattle at ...
... local product advancements and a strong 2012 research pipeline ... growth, Pioneer President Paul E. Schickler told ... "Global trends like an expanding middle class ... demand for food and require constant innovation, global science ...
... March 7, 2012 Palatin Technologies, Inc. (NYSE Amex: ... the 24th Annual ROTH OC Growth Stock Conference on Tuesday, ... will be held at the Ritz Carlton Laguna Niguel in ... and Chief Executive Officer of Palatin Technologies, will provide an ...
Cached Biology Technology:GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI) 2GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI) 3GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI) 4DuPont Leader Overviews 2012 Seed Research Pipeline with Investors 2DuPont Leader Overviews 2012 Seed Research Pipeline with Investors 3
(Date:5/21/2013)... Biologists have known for a long time that some ... well understood, particularly for plants. But it may be ... Australian National University and the U. S. National Evolutionary ... published 21 May in the journal Nature Communications ... faster-changing genomes. , Drawing from a database of global ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... cells in the blood often jump into action ... that can fight off illness. But repeated infections ... leading to the development of serious blood conditions ... led by biologists at the California Institute of ... the molecule microRNA-146a (miR-146a) acts as a critical ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2
... issue of Sports Technology , published by ... the gap between able-bodied athletes and para-athletes, with ... first article, entitled "Biomechanics of double transtibial amputee ... al., compares the sprinting mechanics data of able-bodied ...
... patients with a particularly aggressive form of skin cancer ... from simply hearing that diagnosis, might amplify the progression ... that infers this also suggests that the use of ... of those tumors and therefore improve these patients, quality ...
... Entrust, Inc. (Nasdaq: ENTU ), a world leader in ... fiscal quarter and year ended December 31, 2008.Fourth-Quarter 2008, ... of $24.9 million, a decrease of 7% over Q4 2007; total ... million, an increase of 5%, adjusting for currency , ...
Cached Biology News:Stress may hasten the growth of melanoma tumors 2Stress may hasten the growth of melanoma tumors 3Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 2Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 3Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 4Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 5Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 6Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 7Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 8Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 9Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 10Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 11Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 12Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 13Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 14Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 15Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 16Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 17Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 18Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 19Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 20Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 21
Mycoplasma and virus tested...
... MagicMark and MagicMark XP Western Protein ... and convenient protein molecular weight estimation ... protein contains an IgG binding site, ... antibody-conjugate reagents used to detect your ...
... Immunogen: Synthetic peptide derived ... JAB1 (Jun activation domain-binding protein ... for the JAB1 protein. ... Jurkat cell lysates). Applications: ...
...
Biology Products: